World-class research results in life changing therapies.
From investigating next-generation CAR T cells, oncolytic viruses and immunotherapies to the re-engineering of cancer stem cells, Alliance for Cancer Gene Therapy Research Fellows are world class scientists who work with inspired teams at top institutions to better understand, control and modify a patient’s own cells and genes to eradicate today’s most difficult and deadly cancers. Read what inspires them to work toward cures.
John Maris, MD
Children’s Hospital of Philadelphia
Developing novel cell and gene therapies to target pediatric neuroblastoma with peptide-centric CAR T cells.
Sheila Singh, MD, PhD
McMaster University
Using genetic modifications to understand and defeat pediatric brain cancer.
Juan Fueyo, MD
MD Anderson Cancer Center
ACGT is funding research that uses an oncolytic virus to fight glioblastoma, a deadly type of brain tumor.
Hideho Okada, MD, PhD
University of California San Francisco
ACGT is funding a new clinical trial for children with a rare brain cancer.
Nabil Ahmed, MD
Baylor College of Medicine
Removing immune T cells from a patient, altering their DNA and returning the re-engineered cells to detect and kill solid tumor cancers and tumor stem cells.
John Bell, PhD
Ottawa Hospital Research Institute
Exploring the viability of manipulating a cloned synthetic virus as a potentially safe and effective treatment for glioblastoma.
